Hints and tips:
Related Special Reports
...limited listing in the second board of Frankfurt”....
...“In the negotiations, there is implicitly the threat that if you don’t pay, they will not share the information,” says Thomas Cueni, outgoing head of the International Federation of Pharmaceutical Manufacturers...
...FDA inspections of international plants dropped sharply during the Covid-19 pandemic....
...The World Health Organization last month declared the monkeypox outbreak a public health emergency of international concern — the highest possible designation for a disease under international health regulations...
...“So it is particularly important to protect our limited [stock] of effective anti-fungal drugs.”...
...Discovering this DNA signature of tumours requires whole genome sequencing — reading all 3.2bn letters of genetic code in their DNA — rather than carrying out a more limited panel of genetic tests, which...
...The current draft does not address this and is thus essentially limited to enabling the manufacture of comparatively simple pharmaceutical products, which generally do not require access to information that...
...In second place, with five promotions and demotions, is Hikma Pharmaceuticals....
...In 2016, the UK’s international development agency and CDC (now British International Investment) created MedAccess to do more....
...The new SEC requirements for information in audited financial statements are mostly limited to costs incurred from extreme weather events, as opposed to information on climate risk and emissions reported...
...procurement deal for smallpox vaccines to be used against rising numbers of monkeypox infections in Europe, according to people familiar with the matter, as nations race to secure orders for the relatively limited...
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
...A second phase, which does not yet have a start date, will trial limited commercial sales — from which Curaleaf expects to benefit....
...This has made it harder for Indian organisations to get funding from international philanthropists, putting strains on Tata as it tries to fill the funding gap....
...That’d be bad news for Hikma Pharmaceuticals (27.2 per cent). What about board chairs and their deputies?...
...But critics say the fast food company has been watering down its commitments on antibiotics use and recently published more limited targets....
...“There continues to be limited transparency around goal setting and target disclosure for many E&S metrics,” ISS said....
...Unlike, say, financial or health services, where access to overseas markets is limited by foreign regulators (good luck to a foreign-qualified doctor trying to practice in the US), the main limits on HE...
...For some, the decision is easy, because their exposure is limited....
...Given the BRI’s limited economic impact, some analysts believe that Meloni’s best course would be to maintain the status quo and the deal be renewed automatically....
...At present a very limited number are approved by global regulators for medical use....
...Supplies of the most popular monkey species used by pharmaceutical companies for research, long-tailed macaques, have been strained for several years due to strong demand from researchers and limited US-based...
...Hot stocks include Fu Shou Yuan International Group, China’s biggest cemetery operator. Pharmaceutical companies are also up strongly....
...The World Health Organization declared the monkeypox outbreak a public health emergency of international concern last month....
...Takeda has adopted a cautious approach to investing in vaccines and has a limited pipeline of opportunities....
International Edition